The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Preferential binding of a G-quadruplex ligand to human chromosome ends
Open accessAbstract
The G-overhangs of telomeres are thought to adopt particular conformations, such as T-loops or G-quadruplexes. It has been suggested that G-quadruplex structures could be stabilized by specific ligands in a new approach to cancer treatment consisting in inhibition of telomerase, an enzyme involved in telomere maintenance and cell immortality. Although the formation of G-quadruplexes was demonstrated in vitro many years ago, it has not been definitively demonstrated in living human cells. We therefore investigated the chromosomal binding of a tritiated G-quadruplex ligand, 3H-360A (2,6-N,N'-methyl-quinolinio-3-yl)-pyridine dicarboxamide [methyl-3H]. We verified the in vitro selectivity of 3H-360A for G-quadruplex structures by equilibrium dialysis. We then showed by binding experiments with human genomic DNA that 3H-360A has a very potent selectivity toward G-quadruplex structures of the telomeric 3'-overhang. Finally, we performed autoradiography of metaphase spreads from cells cultured with 3H-360A. We found that 3H-360A was preferentially bound to chromosome terminal regions of both human normal (peripheral blood lymphocytes) and tumor cells (T98G and CEM1301). In conclusion, our results provide evidence that a specific G-quadruplex ligand interacts with the terminal ends of human chromosomes. They support the hypothesis that G-quadruplex ligands induce and/or stabilize G-quadruplex structures at telomeres of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 1×
“Telomerase, the expression of which is repressed in most somatic human cells, is reactivated in most tumors (90%) and is thought to enable cancer cells to proliferate in an unlimited manner, by maintaining and protecting telomeres (1,2).”
Siddiqui-Jain, A., Grand, C. L., Bearss, D. J., & Hurley, L. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182256799 · Cited by 2,238
Crystal structure of parallel quadruplexes from human telomeric DNA
Parkinson, G. N., Lee, M. P. H., & Neidle, S. (2002) · Nature · doi:10.1038/nature755 · Cited by 2,031
Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex
Wang, Y., & Patel, D. J. (1993) · Structure · doi:10.1016/0969-2126(93)90015-9 · Cited by 1,354
Telomere maintenance as a target for anticancer drug discovery
Neidle, S., & Parkinson, G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd793 · Cited by 624
Schaffitzel, C., Berger, I., Postberg, J., Hanes, J., Lipps, H. J., & Plückthun, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141229498 · Cited by 606
Burger, A. M., Dai, F., Schultes, C. M., Reszka, A. P., Moore, M. J., Double, J. A., & Neidle, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2910 · Cited by 587
Sequence and Structural Selectivity of Nucleic Acid Binding Ligands
Ren, J., & Chaires, J. B. (1999) · Biochemistry · doi:10.1021/bi992070s · Cited by 564
Duquette, M. L., Handa, P., Vincent, J. A., Taylor, A. F., & Maizels, N. (2004) · Genes & Development · doi:10.1101/gad.1200804 · Cited by 553
Kim, M.-Y., Vankayalapati, H., Shin-ya, K., Wierzba, K., & Hurley, L. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja017308q · Cited by 525
Telomestatin, a Novel Telomerase Inhibitor from Streptomyces anulatus
Shin-ya, K., Wierzba, K., Matsuo, K.-I., Ohtani, T., Yamada, Y., Furihata, K., Hayakawa, Y., & Seto, H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja005780q · Cited by 509
Human telomeric DNA: G-quadruplex, i-motif and Watson-Crick double helix
Phan, A. T. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf597 · Cited by 471
The structure of telomeric DNA
Neidle, S., & Parkinson, G. N. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00072-1 · Cited by 450
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
Riou, J. F., Guittat, L., Mailliet, P., Laoui, A., Renou, E., Petitgenet, O., Mégnin-Chanet, F., Hélène, C., & Mergny, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052698099 · Cited by 394
Natural and pharmacological regulation of telomerase
Mergny, J.-L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.839 · Cited by 352
New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin
Chan, S. W.-L., & Blackburn, E. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205082 · Cited by 306
Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., & Kelland, L. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12212-2 · Cited by 303
Pennarun, G., Granotier, C., Gauthier, L. R., Gomez, D., Hoffschir, F., Mandine, E., Riou, J.-F., Mergny, J.-L., Mailliet, P., & Boussin, F. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208468 · Cited by 241
Self-citationStabilization of the c-myc gene promoter quadruplex by specific ligands’ inhibitors of telomerase
Lemarteleur, T., Gomez, D., Paterski, R., Mandine, E., Mailliet, P., & Riou, J.-F. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.150 · Cited by 218
Tauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Nakajima, A., Shimamoto, T., Ohyashiki, J. H., & Ohyashiki, K. (2003) · Oncogene · doi:10.1038/sj.onc.1206833 · Cited by 206
Duplex Dissociation of Telomere DNAs Induced by Molecular Crowding
Miyoshi, D., Matsumura, S., Nakano, S.-I., & Sugimoto, N. (2004) · Journal of the American Chemical Society · doi:10.1021/ja036721q · Cited by 181
Detection of Quadruplex DNA Structures in Human Telomeres by a Fluorescent Carbazole Derivative
Chang, C.-C., Kuo, I.-C., Ling, I.-F., Chen, C.-T., Chen, H.-C., Lou, P.-J., Lin, J.-J., & Chang, T.-C. (2004) · Analytical Chemistry · doi:10.1021/ac049510s · Cited by 160
Incles, C. M., Schultes, C. M., Kempski, H., Koehler, H., Kelland, L. R., & Neidle, S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1201.3.10 · Cited by 158
Allosteric, chiral-selective drug binding to DNA
Qu, X., Trent, J. O., Fokt, I., Priebe, W., & Chaires, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200221397 · Cited by 152
Interactions of cryptolepine and neocryptolepine with unusual DNA structures
Guittat, L., Alberti, P., Rosu, F., Miert, S. V., Thetiot, E., Pieters, L. A. C., Gabelica, V., Pauw, E. D., Ottaviani, A., Riou, J., et al. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00035-x · Cited by 147
Interaction of Telomestatin with the Telomeric Single-strand Overhang
Gómez, D., Boujemaa‐Paterski, R., Lemarteleur, T., Shin‐ya, K., Mergny, J., & Riou, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406123200 · Cited by 134
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas, M. A., Reis, R. J. S., Akiyama, M., Koley, H., Chauhan, D., Hideshima, T., Goyal, R. K., Hurley, L. H., Anderson, K. C., & Munshi, N. C. (2003) · PubMed · Cited by 88
Energetics of strand-displacement reactions in triple helices: a spectroscopic study
Mills, M., Arimondo, P. B., Lacroix, L., Garestier, T., Hélène, C., KLUMP, H. H., & Mergny, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3014 · Cited by 58
Targeting human telomerase for cancer therapeutics
Guittat, L., Alberti, P., Gómez, D., Cian, A. D., Pennarun, G., Lemarteleur, T., Belmokhtar, C., Boujemaa‐Paterski, R., Morjani, H., Trentesaux, C., et al. (2004) · Cytotechnology · doi:10.1007/s10616-004-5127-z · Cited by 39
Cited by
G-quadruplexes and their regulatory roles in biology
Rhodes, D., & Lipps, H. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv862 · Cited by 1,487
The Structure and Function of DNA G-Quadruplexes
Spiegel, J., Adhikari, S., & Balasubramanian, S. (2020) · Trends in Chemistry · doi:10.1016/j.trechm.2019.07.002 · Cited by 920
“diolabelled G4 ligands also showed localisation at telomeres [46].”
BackgroundDNA G-quadruplexes in the human genome: detection, functions and therapeutic potential
Hänsel-Hertsch, R., Di Antonio, M., & Balasubramanian, S. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.3 · Cited by 877
A hitchhiker's guide to G-quadruplex ligands
Monchaud, D., & Teulade-Fichou, M.-P. (2008) · Org. Biomol. Chem. · doi:10.1039/b714772b · Cited by 788
5'-UTR RNA G-quadruplexes: translation regulation and targeting
Bugaut, A., & Balasubramanian, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks068 · Cited by 642
Metadata
- Authors
- Granotier, C.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-21
- Volume
- 33
- Issue
- 13
- Pages
- 4182-4190
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2146805637
- Cited by
- 270
- References
- 30
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.